Stroke test company seeks to raise $9 million:
This article was originally published in Clinica
Proteome Sciences is to raise £6 million ($$9.4 million) from an open one for eight offer, priced at 45p. The UK listed company, which was founded in 1984, is developing a blood test for stroke and other disorders, based on changes in protein expression. The Cobham, Surrey-based proteomics company also has in development a high specificity and sensitivity test for Creutzfeldt-Jakob disease (CJD) and other transmissable spongiform encephalopathies.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”